Page last updated: 2024-11-04

sb 239063 and Angiogenesis, Pathologic

sb 239063 has been researched along with Angiogenesis, Pathologic in 2 studies

SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, PC1
Ke, XF1
Kuang, HL1
Pan, LL1
Ye, Q1
Wu, JB1
Ju, H1
Nerurkar, S1
Sauermelch, CF1
Olzinski, AR1
Mirabile, R1
Zimmerman, D1
Lee, JC1
Adams, J1
Sisko, J1
Berova, M1
Willette, RN1

Other Studies

2 other studies available for sb 239063 and Angiogenesis, Pathologic

ArticleYear
BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
    Stem cell research & therapy, 2019, 08-06, Volume: 10, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Bone Morphogenetic Protein 2; Carcinoma, Hepatoc

2019
Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 301, Issue:1

    Topics: Angioplasty, Balloon; Animals; Blood Vessels; Blotting, Western; Cell Division; Cell Movement; Cells

2002